Clinical Trial Update: Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) [Phase 2, Phase 3]

View source ↗

Summary

The update reports the completion of a Phase 2/Phase 3 trial evaluating procalcitonin-guided antibiotic therapy in chronic obstructive pulmonary disease (COPD).…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Danish Procalcitonin Study Group | Conditions: Chronic Obstructive Lung Disease | Phase 2, Phase 3 | Status: COMPLETED